The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endogenous Bioactive Peptides Market Research Report 2025
Synopsis
The global Endogenous Bioactive Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Endogenous Bioactive Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endogenous Bioactive Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Endogenous Bioactive Peptides include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endogenous Bioactive Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endogenous Bioactive Peptides.
The Endogenous Bioactive Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endogenous Bioactive Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endogenous Bioactive Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
by Type
Animal
Vegetal
by Application
Food and Beverages
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endogenous Bioactive Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Endogenous Bioactive Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Endogenous Bioactive Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Endogenous Bioactive Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Endogenous Bioactive Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endogenous Bioactive Peptides is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Endogenous Bioactive Peptides include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endogenous Bioactive Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endogenous Bioactive Peptides.
The Endogenous Bioactive Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endogenous Bioactive Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endogenous Bioactive Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Merck KGaA
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
by Type
Animal
Vegetal
by Application
Food and Beverages
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endogenous Bioactive Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Endogenous Bioactive Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Endogenous Bioactive Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Endogenous Bioactive Peptides Market Overview
1.1 Product Definition
1.2 Endogenous Bioactive Peptides by Type
1.2.1 Global Endogenous Bioactive Peptides Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Animal
1.2.3 Vegetal
1.3 Endogenous Bioactive Peptides by Application
1.3.1 Global Endogenous Bioactive Peptides Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food and Beverages
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Endogenous Bioactive Peptides Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Endogenous Bioactive Peptides Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Endogenous Bioactive Peptides Production Estimates and Forecasts (2019-2030)
1.4.4 Global Endogenous Bioactive Peptides Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Endogenous Bioactive Peptides Production Market Share by Manufacturers (2019-2024)
2.2 Global Endogenous Bioactive Peptides Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Endogenous Bioactive Peptides, Industry Ranking, 2022 VS 2023
2.4 Global Endogenous Bioactive Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Endogenous Bioactive Peptides Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Endogenous Bioactive Peptides, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Endogenous Bioactive Peptides, Product Offered and Application
2.8 Global Key Manufacturers of Endogenous Bioactive Peptides, Date of Enter into This Industry
2.9 Endogenous Bioactive Peptides Market Competitive Situation and Trends
2.9.1 Endogenous Bioactive Peptides Market Concentration Rate
2.9.2 Global 5 and 10 Largest Endogenous Bioactive Peptides Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Endogenous Bioactive Peptides Production by Region
3.1 Global Endogenous Bioactive Peptides Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Endogenous Bioactive Peptides Production Value by Region (2019-2030)
3.2.1 Global Endogenous Bioactive Peptides Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Endogenous Bioactive Peptides by Region (2025-2030)
3.3 Global Endogenous Bioactive Peptides Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Endogenous Bioactive Peptides Production by Region (2019-2030)
3.4.1 Global Endogenous Bioactive Peptides Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Endogenous Bioactive Peptides by Region (2025-2030)
3.5 Global Endogenous Bioactive Peptides Market Price Analysis by Region (2019-2024)
3.6 Global Endogenous Bioactive Peptides Production and Value, Year-over-Year Growth
3.6.1 North America Endogenous Bioactive Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Endogenous Bioactive Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Endogenous Bioactive Peptides Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Endogenous Bioactive Peptides Production Value Estimates and Forecasts (2019-2030)
4 Endogenous Bioactive Peptides Consumption by Region
4.1 Global Endogenous Bioactive Peptides Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Endogenous Bioactive Peptides Consumption by Region (2019-2030)
4.2.1 Global Endogenous Bioactive Peptides Consumption by Region (2019-2030)
4.2.2 Global Endogenous Bioactive Peptides Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Endogenous Bioactive Peptides Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Endogenous Bioactive Peptides Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Endogenous Bioactive Peptides Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Endogenous Bioactive Peptides Production by Type (2019-2030)
5.1.1 Global Endogenous Bioactive Peptides Production by Type (2019-2024)
5.1.2 Global Endogenous Bioactive Peptides Production by Type (2025-2030)
5.1.3 Global Endogenous Bioactive Peptides Production Market Share by Type (2019-2030)
5.2 Global Endogenous Bioactive Peptides Production Value by Type (2019-2030)
5.2.1 Global Endogenous Bioactive Peptides Production Value by Type (2019-2024)
5.2.2 Global Endogenous Bioactive Peptides Production Value by Type (2025-2030)
5.2.3 Global Endogenous Bioactive Peptides Production Value Market Share by Type (2019-2030)
5.3 Global Endogenous Bioactive Peptides Price by Type (2019-2030)
6 Segment by Application
6.1 Global Endogenous Bioactive Peptides Production by Application (2019-2030)
6.1.1 Global Endogenous Bioactive Peptides Production by Application (2019-2024)
6.1.2 Global Endogenous Bioactive Peptides Production by Application (2025-2030)
6.1.3 Global Endogenous Bioactive Peptides Production Market Share by Application (2019-2030)
6.2 Global Endogenous Bioactive Peptides Production Value by Application (2019-2030)
6.2.1 Global Endogenous Bioactive Peptides Production Value by Application (2019-2024)
6.2.2 Global Endogenous Bioactive Peptides Production Value by Application (2025-2030)
6.2.3 Global Endogenous Bioactive Peptides Production Value Market Share by Application (2019-2030)
6.3 Global Endogenous Bioactive Peptides Price by Application (2019-2030)
7 Key Companies Profiled
7.1 American Peptide Company Inc.
7.1.1 American Peptide Company Inc. Endogenous Bioactive Peptides Company Information
7.1.2 American Peptide Company Inc. Endogenous Bioactive Peptides Product Portfolio
7.1.3 American Peptide Company Inc. Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.1.4 American Peptide Company Inc. Main Business and Markets Served
7.1.5 American Peptide Company Inc. Recent Developments/Updates
7.2 Phermpep Co. Ltd.
7.2.1 Phermpep Co. Ltd. Endogenous Bioactive Peptides Company Information
7.2.2 Phermpep Co. Ltd. Endogenous Bioactive Peptides Product Portfolio
7.2.3 Phermpep Co. Ltd. Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Phermpep Co. Ltd. Main Business and Markets Served
7.2.5 Phermpep Co. Ltd. Recent Developments/Updates
7.3 ALEXIS Corporation
7.3.1 ALEXIS Corporation Endogenous Bioactive Peptides Company Information
7.3.2 ALEXIS Corporation Endogenous Bioactive Peptides Product Portfolio
7.3.3 ALEXIS Corporation Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.3.4 ALEXIS Corporation Main Business and Markets Served
7.3.5 ALEXIS Corporation Recent Developments/Updates
7.4 Merck KGaA
7.4.1 Merck KGaA Endogenous Bioactive Peptides Company Information
7.4.2 Merck KGaA Endogenous Bioactive Peptides Product Portfolio
7.4.3 Merck KGaA Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Merck KGaA Main Business and Markets Served
7.4.5 Merck KGaA Recent Developments/Updates
7.5 Promega Corporation
7.5.1 Promega Corporation Endogenous Bioactive Peptides Company Information
7.5.2 Promega Corporation Endogenous Bioactive Peptides Product Portfolio
7.5.3 Promega Corporation Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Promega Corporation Main Business and Markets Served
7.5.5 Promega Corporation Recent Developments/Updates
7.6 Advanced Bioconcept Company
7.6.1 Advanced Bioconcept Company Endogenous Bioactive Peptides Company Information
7.6.2 Advanced Bioconcept Company Endogenous Bioactive Peptides Product Portfolio
7.6.3 Advanced Bioconcept Company Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Advanced Bioconcept Company Main Business and Markets Served
7.6.5 Advanced Bioconcept Company Recent Developments/Updates
7.7 Arlak Biotech
7.7.1 Arlak Biotech Endogenous Bioactive Peptides Company Information
7.7.2 Arlak Biotech Endogenous Bioactive Peptides Product Portfolio
7.7.3 Arlak Biotech Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Arlak Biotech Main Business and Markets Served
7.7.5 Arlak Biotech Recent Developments/Updates
7.8 WN Pharmaceuticals Ltd.
7.8.1 WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Company Information
7.8.2 WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Product Portfolio
7.8.3 WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.8.4 WN Pharmaceuticals Ltd. Main Business and Markets Served
7.8.5 WN Pharmaceuticals Ltd. Recent Developments/Updates
7.9 Anaspec Inc.
7.9.1 Anaspec Inc. Endogenous Bioactive Peptides Company Information
7.9.2 Anaspec Inc. Endogenous Bioactive Peptides Product Portfolio
7.9.3 Anaspec Inc. Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Anaspec Inc. Main Business and Markets Served
7.9.5 Anaspec Inc. Recent Developments/Updates
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Endogenous Bioactive Peptides Company Information
7.10.2 Thermo Fisher Scientific Endogenous Bioactive Peptides Product Portfolio
7.10.3 Thermo Fisher Scientific Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Thermo Fisher Scientific Main Business and Markets Served
7.10.5 Thermo Fisher Scientific Recent Developments/Updates
7.11 Seagarden AS
7.11.1 Seagarden AS Endogenous Bioactive Peptides Company Information
7.11.2 Seagarden AS Endogenous Bioactive Peptides Product Portfolio
7.11.3 Seagarden AS Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Seagarden AS Main Business and Markets Served
7.11.5 Seagarden AS Recent Developments/Updates
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Endogenous Bioactive Peptides Company Information
7.12.2 Novo Nordisk A/S Endogenous Bioactive Peptides Product Portfolio
7.12.3 Novo Nordisk A/S Endogenous Bioactive Peptides Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Novo Nordisk A/S Main Business and Markets Served
7.12.5 Novo Nordisk A/S Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Endogenous Bioactive Peptides Industry Chain Analysis
8.2 Endogenous Bioactive Peptides Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Endogenous Bioactive Peptides Production Mode & Process
8.4 Endogenous Bioactive Peptides Sales and Marketing
8.4.1 Endogenous Bioactive Peptides Sales Channels
8.4.2 Endogenous Bioactive Peptides Distributors
8.5 Endogenous Bioactive Peptides Customers
9 Endogenous Bioactive Peptides Market Dynamics
9.1 Endogenous Bioactive Peptides Industry Trends
9.2 Endogenous Bioactive Peptides Market Drivers
9.3 Endogenous Bioactive Peptides Market Challenges
9.4 Endogenous Bioactive Peptides Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Endogenous Bioactive Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Endogenous Bioactive Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Endogenous Bioactive Peptides Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Endogenous Bioactive Peptides Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Endogenous Bioactive Peptides Production Market Share by Manufacturers (2019-2024)
Table 6. Global Endogenous Bioactive Peptides Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Endogenous Bioactive Peptides Production Value Share by Manufacturers (2019-2024)
Table 8. Global Key Players of Endogenous Bioactive Peptides, Industry Ranking, 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Endogenous Bioactive Peptides as of 2023)
Table 10. Global Market Endogenous Bioactive Peptides Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Global Key Manufacturers of Endogenous Bioactive Peptides, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Endogenous Bioactive Peptides, Product Offered and Application
Table 13. Global Key Manufacturers of Endogenous Bioactive Peptides, Date of Enter into This Industry
Table 14. Global Endogenous Bioactive Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Endogenous Bioactive Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Endogenous Bioactive Peptides Production Value (US$ Million) by Region (2019-2024)
Table 18. Global Endogenous Bioactive Peptides Production Value Market Share by Region (2019-2024)
Table 19. Global Endogenous Bioactive Peptides Production Value (US$ Million) Forecast by Region (2025-2030)
Table 20. Global Endogenous Bioactive Peptides Production Value Market Share Forecast by Region (2025-2030)
Table 21. Global Endogenous Bioactive Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Endogenous Bioactive Peptides Production (Tons) by Region (2019-2024)
Table 23. Global Endogenous Bioactive Peptides Production Market Share by Region (2019-2024)
Table 24. Global Endogenous Bioactive Peptides Production (Tons) Forecast by Region (2025-2030)
Table 25. Global Endogenous Bioactive Peptides Production Market Share Forecast by Region (2025-2030)
Table 26. Global Endogenous Bioactive Peptides Market Average Price (US$/Ton) by Region (2019-2024)
Table 27. Global Endogenous Bioactive Peptides Market Average Price (US$/Ton) by Region (2025-2030)
Table 28. Global Endogenous Bioactive Peptides Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 29. Global Endogenous Bioactive Peptides Consumption by Region (2019-2024) & (Tons)
Table 30. Global Endogenous Bioactive Peptides Consumption Market Share by Region (2019-2024)
Table 31. Global Endogenous Bioactive Peptides Forecasted Consumption by Region (2025-2030) & (Tons)
Table 32. Global Endogenous Bioactive Peptides Forecasted Consumption Market Share by Region (2019-2024)
Table 33. North America Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 34. North America Endogenous Bioactive Peptides Consumption by Country (2019-2024) & (Tons)
Table 35. North America Endogenous Bioactive Peptides Consumption by Country (2025-2030) & (Tons)
Table 36. Europe Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 37. Europe Endogenous Bioactive Peptides Consumption by Country (2019-2024) & (Tons)
Table 38. Europe Endogenous Bioactive Peptides Consumption by Country (2025-2030) & (Tons)
Table 39. Asia Pacific Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 40. Asia Pacific Endogenous Bioactive Peptides Consumption by Region (2019-2024) & (Tons)
Table 41. Asia Pacific Endogenous Bioactive Peptides Consumption by Region (2025-2030) & (Tons)
Table 42. Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 43. Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption by Country (2019-2024) & (Tons)
Table 44. Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption by Country (2025-2030) & (Tons)
Table 45. Global Endogenous Bioactive Peptides Production (Tons) by Type (2019-2024)
Table 46. Global Endogenous Bioactive Peptides Production (Tons) by Type (2025-2030)
Table 47. Global Endogenous Bioactive Peptides Production Market Share by Type (2019-2024)
Table 48. Global Endogenous Bioactive Peptides Production Market Share by Type (2025-2030)
Table 49. Global Endogenous Bioactive Peptides Production Value (US$ Million) by Type (2019-2024)
Table 50. Global Endogenous Bioactive Peptides Production Value (US$ Million) by Type (2025-2030)
Table 51. Global Endogenous Bioactive Peptides Production Value Market Share by Type (2019-2024)
Table 52. Global Endogenous Bioactive Peptides Production Value Market Share by Type (2025-2030)
Table 53. Global Endogenous Bioactive Peptides Price (US$/Ton) by Type (2019-2024)
Table 54. Global Endogenous Bioactive Peptides Price (US$/Ton) by Type (2025-2030)
Table 55. Global Endogenous Bioactive Peptides Production (Tons) by Application (2019-2024)
Table 56. Global Endogenous Bioactive Peptides Production (Tons) by Application (2025-2030)
Table 57. Global Endogenous Bioactive Peptides Production Market Share by Application (2019-2024)
Table 58. Global Endogenous Bioactive Peptides Production Market Share by Application (2025-2030)
Table 59. Global Endogenous Bioactive Peptides Production Value (US$ Million) by Application (2019-2024)
Table 60. Global Endogenous Bioactive Peptides Production Value (US$ Million) by Application (2025-2030)
Table 61. Global Endogenous Bioactive Peptides Production Value Market Share by Application (2019-2024)
Table 62. Global Endogenous Bioactive Peptides Production Value Market Share by Application (2025-2030)
Table 63. Global Endogenous Bioactive Peptides Price (US$/Ton) by Application (2019-2024)
Table 64. Global Endogenous Bioactive Peptides Price (US$/Ton) by Application (2025-2030)
Table 65. American Peptide Company Inc. Endogenous Bioactive Peptides Company Information
Table 66. American Peptide Company Inc. Endogenous Bioactive Peptides Specification and Application
Table 67. American Peptide Company Inc. Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 68. American Peptide Company Inc. Main Business and Markets Served
Table 69. American Peptide Company Inc. Recent Developments/Updates
Table 70. Phermpep Co. Ltd. Endogenous Bioactive Peptides Company Information
Table 71. Phermpep Co. Ltd. Endogenous Bioactive Peptides Specification and Application
Table 72. Phermpep Co. Ltd. Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Phermpep Co. Ltd. Main Business and Markets Served
Table 74. Phermpep Co. Ltd. Recent Developments/Updates
Table 75. ALEXIS Corporation Endogenous Bioactive Peptides Company Information
Table 76. ALEXIS Corporation Endogenous Bioactive Peptides Specification and Application
Table 77. ALEXIS Corporation Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. ALEXIS Corporation Main Business and Markets Served
Table 79. ALEXIS Corporation Recent Developments/Updates
Table 80. Merck KGaA Endogenous Bioactive Peptides Company Information
Table 81. Merck KGaA Endogenous Bioactive Peptides Specification and Application
Table 82. Merck KGaA Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Merck KGaA Main Business and Markets Served
Table 84. Merck KGaA Recent Developments/Updates
Table 85. Promega Corporation Endogenous Bioactive Peptides Company Information
Table 86. Promega Corporation Endogenous Bioactive Peptides Specification and Application
Table 87. Promega Corporation Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Promega Corporation Main Business and Markets Served
Table 89. Promega Corporation Recent Developments/Updates
Table 90. Advanced Bioconcept Company Endogenous Bioactive Peptides Company Information
Table 91. Advanced Bioconcept Company Endogenous Bioactive Peptides Specification and Application
Table 92. Advanced Bioconcept Company Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Advanced Bioconcept Company Main Business and Markets Served
Table 94. Advanced Bioconcept Company Recent Developments/Updates
Table 95. Arlak Biotech Endogenous Bioactive Peptides Company Information
Table 96. Arlak Biotech Endogenous Bioactive Peptides Specification and Application
Table 97. Arlak Biotech Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Arlak Biotech Main Business and Markets Served
Table 99. Arlak Biotech Recent Developments/Updates
Table 100. WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Company Information
Table 101. WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Specification and Application
Table 102. WN Pharmaceuticals Ltd. Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. WN Pharmaceuticals Ltd. Main Business and Markets Served
Table 104. WN Pharmaceuticals Ltd. Recent Developments/Updates
Table 105. Anaspec Inc. Endogenous Bioactive Peptides Company Information
Table 106. Anaspec Inc. Endogenous Bioactive Peptides Specification and Application
Table 107. Anaspec Inc. Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Anaspec Inc. Main Business and Markets Served
Table 109. Anaspec Inc. Recent Developments/Updates
Table 110. Thermo Fisher Scientific Endogenous Bioactive Peptides Company Information
Table 111. Thermo Fisher Scientific Endogenous Bioactive Peptides Specification and Application
Table 112. Thermo Fisher Scientific Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Thermo Fisher Scientific Main Business and Markets Served
Table 114. Thermo Fisher Scientific Recent Developments/Updates
Table 115. Seagarden AS Endogenous Bioactive Peptides Company Information
Table 116. Seagarden AS Endogenous Bioactive Peptides Specification and Application
Table 117. Seagarden AS Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Seagarden AS Main Business and Markets Served
Table 119. Seagarden AS Recent Developments/Updates
Table 120. Novo Nordisk A/S Endogenous Bioactive Peptides Company Information
Table 121. Novo Nordisk A/S Endogenous Bioactive Peptides Specification and Application
Table 122. Novo Nordisk A/S Endogenous Bioactive Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Novo Nordisk A/S Main Business and Markets Served
Table 124. Novo Nordisk A/S Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Endogenous Bioactive Peptides Distributors List
Table 128. Endogenous Bioactive Peptides Customers List
Table 129. Endogenous Bioactive Peptides Market Trends
Table 130. Endogenous Bioactive Peptides Market Drivers
Table 131. Endogenous Bioactive Peptides Market Challenges
Table 132. Endogenous Bioactive Peptides Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Endogenous Bioactive Peptides
Figure 2. Global Endogenous Bioactive Peptides Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Endogenous Bioactive Peptides Market Share by Type: 2023 VS 2030
Figure 4. Animal Product Picture
Figure 5. Vegetal Product Picture
Figure 6. Global Endogenous Bioactive Peptides Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Endogenous Bioactive Peptides Market Share by Application: 2023 VS 2030
Figure 8. Food and Beverages
Figure 9. Cosmetics
Figure 10. Others
Figure 11. Global Endogenous Bioactive Peptides Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Endogenous Bioactive Peptides Production Value (US$ Million) & (2019-2030)
Figure 13. Global Endogenous Bioactive Peptides Production Capacity (Tons) & (2019-2030)
Figure 14. Global Endogenous Bioactive Peptides Production (Tons) & (2019-2030)
Figure 15. Global Endogenous Bioactive Peptides Average Price (US$/Ton) & (2019-2030)
Figure 16. Endogenous Bioactive Peptides Report Years Considered
Figure 17. Endogenous Bioactive Peptides Production Share by Manufacturers in 2023
Figure 18. Endogenous Bioactive Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Endogenous Bioactive Peptides Revenue in 2023
Figure 20. Global Endogenous Bioactive Peptides Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Endogenous Bioactive Peptides Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Endogenous Bioactive Peptides Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 23. Global Endogenous Bioactive Peptides Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Endogenous Bioactive Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Endogenous Bioactive Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Endogenous Bioactive Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Endogenous Bioactive Peptides Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Global Endogenous Bioactive Peptides Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 29. Global Endogenous Bioactive Peptides Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 31. North America Endogenous Bioactive Peptides Consumption Market Share by Country (2019-2030)
Figure 32. U.S. Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 33. Canada Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 34. Europe Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 35. Europe Endogenous Bioactive Peptides Consumption Market Share by Country (2019-2030)
Figure 36. Germany Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 37. France Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 38. U.K. Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 39. Italy Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 40. Russia Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 41. Asia Pacific Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 42. Asia Pacific Endogenous Bioactive Peptides Consumption Market Share by Region (2025-2030)
Figure 43. China Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 44. Japan Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 45. South Korea Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 46. China Taiwan Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 47. Southeast Asia Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 48. India Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 49. Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 50. Latin America, Middle East & Africa Endogenous Bioactive Peptides Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 52. Brazil Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 53. Turkey Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 54. GCC Countries Endogenous Bioactive Peptides Consumption and Growth Rate (2019-2030) & (Tons)
Figure 55. Global Production Market Share of Endogenous Bioactive Peptides by Type (2019-2030)
Figure 56. Global Production Value Market Share of Endogenous Bioactive Peptides by Type (2019-2030)
Figure 57. Global Endogenous Bioactive Peptides Price (US$/Ton) by Type (2019-2030)
Figure 58. Global Production Market Share of Endogenous Bioactive Peptides by Application (2019-2030)
Figure 59. Global Production Value Market Share of Endogenous Bioactive Peptides by Application (2019-2030)
Figure 60. Global Endogenous Bioactive Peptides Price (US$/Ton) by Application (2019-2030)
Figure 61. Endogenous Bioactive Peptides Value Chain
Figure 62. Endogenous Bioactive Peptides Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
